Pearl IRB Granted AAHRPP Accreditation
INDIANAPOLIS, INDIANA – February 17, 2015 - Pearl IRB, LLC a provider of superior central IRB review services, is proud to announce its recent accreditation by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). Pearl IRB earned this distinction in December 2014 by demonstrating extensive safeguards in all levels of the research operations and abiding by high standards of excellence for all research.
Pearl IRB now joins an elite group of 23 commercial-independent IRB’s who hold this prestigious designation. Additionally, Pearl IRB joins Indiana University as just the second AAHRPP accredited organization in the state of Indiana.1
“We are extremely proud to have earned AAHRPP accreditation. This accreditation validates our commitment to high quality research processes and organizational excellence,” shares Pearl IRB’s President and CEO, Diana Caldwell. Pearl IRB is further differentiated by being one of only five AAHRPP accredited, commercial-independent IRB’s to also receive WBENC (Women’s Business Enterprise National Council) certification as a Women’s Business Enterprise WBE). Caldwell highlights, “Our clients want to work first and foremost with an IRB that demonstrates excellence, but many also have the business objective of engaging with diverse suppliers in the clinical research space. With Pearl IRB, they get both.”
To date, there are more than 200 AAHRPP accredited organizations in 46 states and 10 different countries.1 AAHRPP promotes high-quality research through an accreditation process that helps organizations worldwide strengthen their human research protection programs (HRPPs).
To earn AAHRPP accreditation Pearl IRB completed a voluntary, peer-driven process and provided tangible evidence through policies, procedures, and practices of its commitment to scientifically and ethically sound research and to continuous improvement. Historically, this process can take years to complete - Pearl IRB moved from Phase 1 submission to accredited in just 6 months.
As the "gold seal," AAHRPP accreditation offers assurances that Pearl IRB demonstrates its value in providing excellence and following high standards for quality, ethics, and protection to research participants, researchers, sponsors, government regulators, and the general public.
To learn more about Pearl IRB, visit www.pearlirb.com or email info@pearlirb.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
